In clinical phase II studies. the efficacy of a promising therapy is tested in patients for the first time. Based on the results. it is decided whether the development programme should be stopped or whether the benefit-risk profile is promising enough to justify the initiation of large phase III studies. https://hollandscountryclothinges.shop/product-category/horse-turnout-boots/